Vectors Research Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Vectors Research Management’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-505	Closed	–	–	502
2019 Q2	$0	Hold	505	–	–	﹤0.01%	445
2019 Q1	$2K	Hold	505	–	–	﹤0.01%	398
2018 Q4	$2K	Hold	505	–	–	﹤0.01%	611
2018 Q3	$4K	Buy	+505	New	+$4.03K	﹤0.01%	407

Vectors Research Management's INSY Position: Q3 2019 in Review

Vectors Research Management sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 505 shares.

Vectors Research Management first reported a position in INSY in Q3 2018 and held it in 4 quarters. The position peaked at $4K in Q3 2018. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.

Vectors Research Management reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Vectors Research Management sold 505 Insys Therapeutics, Inc. shares in Q3 2019.
Vectors Research Management first reported a position in Insys Therapeutics, Inc. in Q3 2018 and held it in 4 quarters.
Vectors Research Management's Insys Therapeutics, Inc. position peaked at $4K in Q3 2018.
4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.

Based on Vectors Research Management's 13F filing for Q3 2019, filed 15 Nov 2019.